Neuropeptide Y modulation of sympathetic activity in myocardial infarction
S Basu,
SK Sinha,
Q Shao,
PK Ganguly,
and
NS Dhalla
Department of Anatomy, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.
OBJECTIVES: We examined the possible effect of neuropeptide Y in modulating central sympathetic activity after myocardial infarction in rats. BACKGROUND: Previous studies have shown the coexistence of neuropeptide Y and norepinephrine in the brain and a possible functional interaction between the two. Neuropeptide Y inhibits the release of norepinephrine at the presynaptic level and can be considered to act as a neuromodulator. METHODS: Two groups of rats were examined in this study-an experimental group, defined as those rats undergoing left coronary artery ligation, and a sham group without coronary artery ligation, serving as the control group. The animal in both groups underwent microdialysis in the paraventricular nucleus at 2, 4 and 8 weeks after operation. Microdialysis samples were collected with and without injecting neuropeptide Y in the paraventricular nucleus. The concentration of norepinephrine was determined by injecting purified microdialysate samples during high performance liquid chromatography. To explore the receptor's possible role, autoradiographic localization of neuropeptide Y receptors in the paraventricular nucleus was also carried out in the experimental and sham groups. RESULTS: The concentration of norepinephrine measured in the samples was decreased by 50% with neuropeptide Y in 2- and 4-week old rats after infarction, but by only 20% (p < 0.05) in 8-week old rats after infraction. The diminished inhibitory effects of neuropeptide Y on norepinephrine release was associated with increased sympathetic activity, as reflected by plasma norepinephrine; 8-week old rats after infarction had almost a 100% (p < 0.05) increase in their plasma norepinephrine level compared with the sham group. Autoradiography revealed a significant decrease in density of neuropeptide Y receptors in the paraventricular nucleus in 8-week old rats after infarction (p < 0.05). CONCLUSIONS: The data presented in this report suggest that the reduction of the inhibitory activation of neuropeptide Y on sympathetic release may contribute to elevated norepinephrine levels after myocardial infarction.
This article has been cited by other articles:
|
|
|
|
 
T. H. Han, K. Lee, J. B. Park, D. Ahn, J.-H. Park, D.-Y. Kim, J. E. Stern, S. Y. Lee, and P. D. Ryu
Reduction in synaptic GABA release contributes to target-selective elevation of PVN neuronal activity in rats with myocardial infarction
Am J Physiol Regulatory Integrative Comp Physiol,
July 1, 2010;
299(1):
R129 - R139.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-M. Kang, R.-L. He, L.-M. Yang, D.-N. Qin, A. Guggilam, C. Elks, N. Yan, Z. Guo, and J. Francis
Brain tumour necrosis factor-{alpha} modulates neurotransmitters in hypothalamic paraventricular nucleus in heart failure
Cardiovasc Res,
September 1, 2009;
83(4):
737 - 746.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. S. Dhalla, M. R. Dent, P. S. Tappia, R. Sethi, J. Barta, and R. K. Goyal
Subcellular Remodeling as a Viable Target for the Treatment of Congestive Heart Failure
Journal of Cardiovascular Pharmacology and Therapeutics,
March 1, 2006;
11(1):
31 - 45.
[Abstract]
[PDF]
|
|
|
|
|
|
|
Q. Shao, B. Ren, V. Elimban, P. S. Tappia, N. Takeda, and N. S. Dhalla
Modification of sarcolemmal Na+-K+-ATPase and Na+/Ca2+ exchanger expression in heart failure by blockade of renin-angiotensin system
Am J Physiol Heart Circ Physiol,
June 1, 2005;
288(6):
H2637 - H2646.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Q. Shao, B. Ren, H. K. Saini, T. Netticadan, N. Takeda, and N. S. Dhalla
Sarcoplasmic reticulum Ca2+ transport and gene expression in congestive heart failure are modified by imidapril treatment
Am J Physiol Heart Circ Physiol,
April 1, 2005;
288(4):
H1674 - H1682.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z.-H. Zhang, S.-G. Wei, J. Francis, and R. B. Felder
Cardiovascular and renal sympathetic activation by blood-borne TNF-alpha in rat: the role of central prostaglandins
Am J Physiol Regulatory Integrative Comp Physiol,
April 1, 2003;
284(4):
R916 - R927.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. B. Felder, J. Francis, Z.-H. Zhang, S.-G. Wei, R. M. Weiss, and A. K. Johnson
Heart failure and the brain: new perspectives
Am J Physiol Regulatory Integrative Comp Physiol,
February 1, 2003;
284(2):
R259 - R276.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. K. Sharma, D. Chapman, R. Temsah, T. Netticadan, D. P. Brasil, and N. S. Dhalla
Prevention of Vascular Apoptosis in Myocardial Infarction by Losartan
Journal of Cardiovascular Pharmacology and Therapeutics,
January 1, 1999;
4(2):
77 - 84.
[Abstract]
[PDF]
|
|
|
|
|
|
|
F. Vahid-Ansari and F. H. H. Leenen
Pattern of neuronal activation in rats with CHF after myocardial infarction
Am J Physiol Heart Circ Physiol,
December 1, 1998;
275(6):
H2140 - H2146.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
